1. Von Stebut E. Leishmaniasis and other protozoan infections. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, et al., editors. Fitzpatrick's Dermatology. 9th ed. New York: McGraw-Hill Publishing; 2019. pp. 3228-3231
2. Downing C, Tyring S. Parasitic disease. In: Burns T, Breathnach S, Neil C, Griffiths C, editors. Rook's Textbook of Dermatology. 9th ed. West Susex: Blackwell Publishing Ltd; 2012. pp. 1061-1064
3. Arevalo J, Ramirez L, Adaui V, Zimic M, Tulliano G, Miranda-Verástegui C, et al. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis. Journal of Infectious Diseases. 2007;195(12):1846-1851. DOI: 10.1086/518041
4. Soto J, Arana BA, Toledo J, et al. Miltefosine for new world cutaneous leishmaniasis. Clinical Infectious Disease. 2004;38:1266-1272
5. Tripathi KD. Essentials of Medical Pharmacology. 8th ed. New Delhi, India: Jaypee Brothers Medical; 2018